z-logo
open-access-imgOpen Access
The PARADISE‐MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMI
Author(s) -
Bellis Alessandro,
Mauro Ciro,
Barbato Emanuele,
Trimarco Bruno,
Morisco Carmine
Publication year - 2022
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.14159
Subject(s) - medicine , cardiology , myocardial infarction , ejection fraction , heart failure , valsartan , enalapril , ramipril , ventricular remodeling , clinical endpoint , ace inhibitor , percutaneous coronary intervention , angiotensin converting enzyme , randomized controlled trial , blood pressure

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom